Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study.

Trompet S, de Craen AJ, Slagboom P, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Ford I, Gaw A, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Jukema JW; PROSPER Group.

Exp Gerontol. 2008 Aug;43(8):801-5. doi: 10.1016/j.exger.2008.04.006. Epub 2008 Apr 22.

PMID:
18504081
2.

Polymorphisms in the lymphotoxin alpha gene and the risk of ischemic stroke in the Japanese population. The Fukuoka Stroke Registry and the Hisayama Study.

Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M.

Cerebrovasc Dis. 2008;25(5):417-22. doi: 10.1159/000121342. Epub 2008 Mar 17.

PMID:
18349535
3.
4.

Lymphotoxin-alpha polymorphisms and presence of cancer in 1,536 consecutive autopsy cases.

Takei K, Ikeda S, Arai T, Tanaka N, Muramatsu M, Sawabe M.

BMC Cancer. 2008 Aug 13;8:235. doi: 10.1186/1471-2407-8-235.

5.

Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction.

Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T, Sato H, Sato H, Hori M, Nakamura Y, Tanaka T.

Nat Genet. 2002 Dec;32(4):650-4. Epub 2002 Nov 11. Erratum in: Nat Genet. 2003 Jan;33(1):107..

PMID:
12426569
6.

Galectin-2 3279TT variant protects against the lymphotoxin-alpha 252GG genotype associated ischaemic stroke.

Szolnoki Z, Maasz A, Magyari L, Horvatovich K, Farago B, Kondacs A, Bodor A, Hadarits F, Orosz P, Ille A, Melegh B.

Clin Neurol Neurosurg. 2009 Apr;111(3):227-30. doi: 10.1016/j.clineuro.2008.09.027. Epub 2008 Nov 14.

PMID:
19013708
7.

Low complement C4B gene copy number predicts short-term mortality after acute myocardial infarction.

Blaskó B, Kolka R, Thorbjornsdottir P, Sigurdarson ST, Sigurdsson G, Rónai Z, Sasvári-Székely M, Bödvarsson S, Thorgeirsson G, Prohászka Z, Kovács M, Füst G, Arason GJ.

Int Immunol. 2008 Jan;20(1):31-7. Epub 2007 Nov 20.

PMID:
18032375
8.

Lack of association between LTA and LGALS2 polymorphisms and myocardial infarction in Japanese and Korean populations.

Kimura A, Takahashi M, Choi BY, Bae SW, Hohta S, Sasaoka T, Nakahara KI, Chida K, Sawabe M, Yasunami M, Naruse T, Izumi T, Park JE.

Tissue Antigens. 2007 Mar;69(3):265-9.

PMID:
17493152
9.

Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary atherosclerosis.

Laxton R, Pearce E, Kyriakou T, Ye S.

Genes Immun. 2005 Sep;6(6):539-41.

PMID:
15973460
10.

Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans.

Koch W, Hoppmann P, Michou E, Jung V, Pfeufer A, Mueller JC, Gieger C, Wichmann HE, Meitinger T, Schömig A, Kastrati A.

Hum Mol Genet. 2007 Aug 1;16(15):1821-7. Epub 2007 May 21.

PMID:
17517687
11.

The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.

Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, Hedner T, Melander O.

J Hypertens. 2009 Apr;27(4):769-73. doi: 10.1097/HJH.0b013e328326f7eb.

PMID:
19293724
12.

Decreased mortality associated with statin treatment in patients with acute myocardial infarction and lymphotoxin-alpha C804A polymorphism.

Suna S, Sakata Y, Nakatani D, Okuda K, Shimizu M, Usami M, Matsumoto S, Hara M, Ozaki K, Mizuno H, Minamino T, Takashima S, Nishino M, Matsumura Y, Takeda H, Tanaka T, Sato H, Hori M, Komuro I.

Atherosclerosis. 2013 Apr;227(2):373-9. doi: 10.1016/j.atherosclerosis.2013.01.020. Epub 2013 Jan 25.

PMID:
23398946
13.

Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy.

Ramasawmy R, Fae KC, Cunha-Neto E, Müller NG, Cavalcanti VL, Ferreira RC, Drigo SA, Ianni B, Mady C, Goldberg AC, Kalil J.

J Infect Dis. 2007 Dec 15;196(12):1836-43. doi: 10.1086/523653.

PMID:
18190265
14.

An association study in essential hypertension using functional polymorphisms in lymphotoxin-alpha gene.

Nakayama T, Soma M, Sato N, Haketa A, Kosuge K, Aoi N, Sato M, Izumi Y, Matsumoto K, Kanmatsuse K, Kokubun S.

Am J Hypertens. 2004 Nov;17(11 Pt 1):1045-9.

PMID:
15533732
15.

Inflammation as a risk factor for myocardial infarction.

Tanaka T, Ozaki K.

J Hum Genet. 2006;51(7):595-604. Epub 2006 Jun 13. Review.

PMID:
16770523
16.

Association between lymphotoxin alpha (-252 A/G and -804 C/A) gene polymorphisms and risk of stroke in North Indian population: a hospital-based case-control study.

Kumar P, Kumar A, Misra S, Faruq M, Vivekanandhan S, Srivastava AK, Prasad K.

Int J Neurosci. 2016 Dec;126(12):1127-35. doi: 10.3109/00207454.2015.1134527. Epub 2016 Jan 20.

PMID:
26707826
17.

Polymorphisms of the LTA gene may contribute to the risk of myocardial infarction: a meta-analysis.

Li N, Liu R, Zhai H, Li L, Yin Y, Zhang J, Xia Y.

PLoS One. 2014 Mar 18;9(3):e92272. doi: 10.1371/journal.pone.0092272. eCollection 2014.

18.

Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro.

Ozaki K, Inoue K, Sato H, Iida A, Ohnishi Y, Sekine A, Sato H, Odashiro K, Nobuyoshi M, Hori M, Nakamura Y, Tanaka T.

Nature. 2004 May 6;429(6987):72-5.

PMID:
15129282
19.

Lymphotoxin-alpha polymorphism and the risk of cervical cancer in Japanese subjects.

Niwa Y, Hirose K, Matsuo K, Tajima K, Ikoma Y, Nakanishi T, Nawa A, Kuzuya K, Tamakoshi A, Hamajima N.

Cancer Lett. 2005 Jan 31;218(1):63-8.

PMID:
15639341
20.

Polymorphisms of tumor necrosis factor alpha gene and coronary heart disease in a Chinese Han population: interaction with cigarette smoking.

Hou L, Huang J, Lu X, Wang L, Fan Z, Gu D.

Thromb Res. 2009 Apr;123(6):822-6. doi: 10.1016/j.thromres.2008.07.016. Epub 2008 Sep 23.

PMID:
18814905

Supplemental Content

Support Center